Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Céline Dubuquoy"'
Autor:
Marthe Moldes, Fabienne Foufelle, Françoise Lasnier, Catherine Postic, Isabelle Dugail, Jean Girard, Céline Dubuquoy, Anne-Françoise Burnol, Clotilde Langlois, Céline Robichon
Publikováno v:
Journal of Hepatology. 55:145-153
Background & Aims The adiponutrin/PNPLA3 (patatin-like phospholipase domain-containing protein 3) variant I148M has recently emerged as an important marker of human fatty liver disease. In order to understand the role of the adiponutrin/PNPLA3 protei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9c3f495262aa162ba03ebd97a12adbb2
https://doi.org/10.1016/j.jhep.2010.10.024
https://doi.org/10.1016/j.jhep.2010.10.024
Autor:
Catherine Postic, Fadila Rayah-Benhamed, Solenne Marmier, Céline Guinez, Xiaoyong Yang, Anne-Françoise Burnol, Gaëlle Filhoulaud, Renaud Dentin, Jean Girard, Marthe Moldes, Céline Dubuquoy, Tony Lefebvre
Publikováno v:
Diabetes
Diabetes, 2011, 60 (5), pp.1399-1413. ⟨10.2337/db10-0452⟩
Diabetes, 2011, 60 (5), pp.1399-1413. ⟨10.2337/db10-0452⟩
OBJECTIVE Carbohydrate-responsive element–binding protein (ChREBP) is a key transcription factor that mediates the effects of glucose on glycolytic and lipogenic genes in the liver. We have previously reported that liver-specific inhibition of ChRE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d3ef33ad4d69daac6f57b9f8069a3d1
https://doi.org/10.2337/db10-0452
https://doi.org/10.2337/db10-0452
Autor:
Chiara Sartor, François Guillonneau, Philippe Veber, Laura Bachelot, Anne-Françoise Burnol, Angélique Gougelet, Cyril Torre, Albert Braeuning, Pierre-Damien Denechaud, Christine Perret, Céline Dubuquoy, Michael Schwarz, Cécile Godard, Tao Ye, Sabine Colnot, Marthe Moldes, Benoit Terris
Publikováno v:
Hepatology
Hepatology, 2014, 59 (6), pp.2344-2357. ⟨10.1002/hep.26924⟩
Hepatology, Wiley-Blackwell, 2014, 59 (6), pp.2344-2357. ⟨10.1002/hep.26924⟩
Hepatology, 2014, 59 (6), pp.2344-2357. ⟨10.1002/hep.26924⟩
Hepatology, Wiley-Blackwell, 2014, 59 (6), pp.2344-2357. ⟨10.1002/hep.26924⟩
β-catenin signaling can be both a physiological and oncogenic pathway in the liver. It controls compartmentalized gene expression, allowing the liver to ensure its essential metabolic function. It is activated by mutations in 20%-40% of hepatocellul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac478b4696f8f5be70be29e786be27d5
https://www.hal.inserm.fr/inserm-02532861
https://www.hal.inserm.fr/inserm-02532861
Publikováno v:
Clinics and research in hepatology and gastroenterology. 37(1)
Non-alcoholic fatty liver disease (NAFLD) is an emerging epidemic disease. It represents a large spectrum of liver diseases, and affects both adults and children. The etiology of NAFLD is multifactorial. Indeed, several events such as caloric imbalan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc05e51ac2a5a87feba0df0b9390910f
https://pubmed.ncbi.nlm.nih.gov/22884299
https://pubmed.ncbi.nlm.nih.gov/22884299
Autor:
R. Cabrae, Sandra Guilmeau, Anne-Françoise Burnol, H. Guillou, Bruno Fève, Catherine Postic, Marthe Moldes, B. Noblet, Céline Dubuquoy, Lucille Morzyglod
Publikováno v:
Diabetes & Metabolism. 41:A82
Introduction La voie Wnt/β-catenine joue un role essentiel dans le foie controlant le metabolisme azote et glucidique. Elle est activee par la liaison de ligands Wnts, qui subissent plusieurs modifications post-traductionnelles, notamment des acylat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8cb2b564fd6f5febac1907a806544bbf
https://doi.org/10.1016/s1262-3636(15)30309-8
https://doi.org/10.1016/s1262-3636(15)30309-8
Autor:
H. Guillou, F. Briand, Catherine Postic, B. Prunet-Marcassus, T. Al Saati, T. Sulpice, Céline Dubuquoy, I. Urbain
Publikováno v:
Diabetes & Metabolism. 40:A89
Introduction La prevalence des NAFLD, manifestation hepatique du syndrome metabolique, est en constante augmentation dans les pays industrialises. Ainsi, la mise au point de modeles animaux atteints de syndrome metabolique et de NAFLD est importante
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::83f4ef62fcf9a30e7385467e70d733e0
https://doi.org/10.1016/s1262-3636(14)72551-0
https://doi.org/10.1016/s1262-3636(14)72551-0
Autor:
Cabrae, Régine1, Dubuquoy, Céline1, Caüzac, Michèle1, Morzyglod, Lucille1, Guilmeau, Sandra1, Noblet, Bénédicte1, Fève, Bruno2, Postic, Catherine1, Burnol, Anne-Françoise1, Moldes, Marthe1,3 marthe.moldes@inserm.fr
Publikováno v:
Scientific Reports. 3/20/2020, Vol. 10 Issue 1, p1-10. 10p.
Publikováno v:
Archives of Toxicology; Jan2019, Vol. 93 Issue 1, p107-119, 13p, 1 Chart, 5 Graphs